Visiox Pharma Drug Patent Portfolio

Visiox Pharma owns 1 orange book drug protected by 11 US patents Given below is the list of Visiox Pharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11666563 Pharmaceutical preparation containing pyridyl aminoacetic acid compound 16 Jul, 2039
Active
US10774072 Crystal of N-substituted sulfonamide compound 10 Jun, 2035
Active
US10179127 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
Active
US10702511 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
Active
US10765750 Pharmaceutical composition containing pyridylaminoacetic acid compound 08 Jan, 2035
Active
US11197849 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
Active
US11793798 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
Active
US9415038 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
Active
USRE48183 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
Active
US8648097 Pyridylaminoacetic acid compound 13 Oct, 2029
Active
US8685986 Medical composition for treatment or prophylaxis of glaucoma 13 Oct, 2029
Active


Given below is the list of recent legal activities going on the following drug patents of Visiox Pharma.

Activity Date Patent Number
Patent litigations
Paralegal Petition Decision 27 Jun, 2024 US8685986
Paralegal Petition Decision 27 Jun, 2024 US10702511
Petition Entered 22 May, 2024 US8685986
Second letter to regulating agency to determine regulatory review period 07 May, 2024 US10702511
Second letter to regulating agency to determine regulatory review period 07 May, 2024 US8685986
Payment of Maintenance Fee, 4th Year, Large Entity 28 Feb, 2024 US10774072
Payment of Maintenance Fee, 4th Year, Large Entity 21 Feb, 2024 US10765750
Payment of Maintenance Fee, 8th Year, Large Entity 31 Jan, 2024 US9415038
Letter from FDA or Dept of Agriculture re PTE application 30 Jan, 2024 US10702511
Letter from FDA or Dept of Agriculture re PTE application 30 Jan, 2024 US8685986
Payment of Maintenance Fee, 4th Year, Large Entity 20 Dec, 2023 US10702511
Change in Power of Attorney (May Include Associate POA) 13 Nov, 2023 US8685986
Recordation of Patent eGrant 24 Oct, 2023 US11793798
Recordation of Patent Grant Mailed 24 Oct, 2023 US11793798
Email Notification 24 Oct, 2023 US11793798


Visiox Pharma's Family Patents

Visiox Pharma drugs have patent protection in a total of 31 countries. It's US patent count contributes only to 15.6% of its total global patent coverage. Click below to unlock the full patent family tree.

Family Patents



Visiox Pharma Drug List

Given below is the complete list of Visiox Pharma's drugs and the patents protecting them.


1. Omlonti

Omlonti is protected by 11 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11666563 Pharmaceutical preparation containing pyridyl aminoacetic acid compound 16 Jul, 2039
(14 years from now)
Active
US10774072 Crystal of N-substituted sulfonamide compound 10 Jun, 2035
(10 years from now)
Active
US10179127 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
(10 years from now)
Active
US10702511 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
(10 years from now)
Active
US10765750 Pharmaceutical composition containing pyridylaminoacetic acid compound 08 Jan, 2035
(10 years from now)
Active
US11197849 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
(10 years from now)
Active
US11793798 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
(10 years from now)
Active
US9415038 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
(10 years from now)
Active
USRE48183 Pharmaceutical formulations comprising a pyridylaminoacetic acid compound 08 Jan, 2035
(10 years from now)
Active
US8648097 Pyridylaminoacetic acid compound 13 Oct, 2029
(5 years from now)
Active
US8685986 Medical composition for treatment or prophylaxis of glaucoma 13 Oct, 2029
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Omlonti's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List